Publication | Closed Access

PD-L1 testing of non-small cell lung cancer using different antibodies and platforms: a Swiss cross-validation study

OncologyCancer DetectionMedicineMultiple Pulmonary NoduleImmunologyPd-l1 TestingPathologyDifferent AntibodiesBronchial NeoplasmImmune Checkpoint InhibitorSwiss Cross-validation StudyLung CancerMolecular DiagnosticsRadiation OncologyTumor Microenvironment